PMH1: RIGOROUS CRITERIA FOR TREATMENT RESPONSE DIFFERENTIATED EFFICACY OF OLANZAPINE VERSUS HALOPERIDOL IN PATIENTS WITH SCHIZOPHRENIA
- 作者BJ Kinon; Z Zhao; BL Barber; JA Gilmore
- 卷第4卷
- 期第6期
- 文件大小71.01KB
- 发表时间2001
- DOI10.1016/s1098-3015(11)71610-2
- 页码450-451
Dispensing Patterns and Cost of Insulins in Poland Between 2012 and 2015Sliwczynski, A; Brzozowska, M; Wierzba, W; Orlewska, K; Milkowski, M; Orlewska, E · Value in Health · 2016
Direct Medical Costs of Multiple Sclerosis and Regional Diversity in Access to Disease-Modifying Therapies in Poland Between 2008-2016Orlewska, K; Sliwczynski, A; Brzozowska, M; Wierzba, W; Marczak, M; Orlewska, E · Value in Health · 2017
Real-World Comorbidities, Treatment Pattern and Cost of Patients with Acromegaly in Poland Based on Retrospective Analysis Of Administrative Claims DataSliwczynski, A; Brzozowska, M; Labenda, A; Orlewska, K; Milkowski, M; Orlewska, E · Value in Health · 2016
Editorial BoardSzafraniec-Burylo, S.I.; Orlewska, E.; Rupinski, R.; Filipowicz-Sosnowska, A. · Rheumatic Disease Clinics of North America · 1998
ROYAL NAVAL MEDICAL SERVICEOrlewska, E.; Gulacsi, L. · The Lancet · 1938
Economic aspects in medical decision-makingE Orlewska · 2003
Loss of Productivity in Polish Patients with Rheumatoid ArthritisSzafraniec-Burylo, S.I.; Orlewska, E.; Rupinski, R.; Filipowicz-Sosnowska, A. · Value in Health · 2013
PCV88 TREATMENT PATTERN, RESOURCE UTILIZATION AND COSTS OF INPATIENTTHROMBOPROPHYLAXIS IN POLANDE Orlewska; J Lis · 2005